Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Botulinum Neurotoxin Revisited – An Individualised, Patient-centric Approach for the Treatment of Dystonia and Spasticity (CROSBI ID 227305)

Prilog u časopisu | pregledni rad (stručni)

Relja, Maja ; Jacinto, Jorge ; Jankovic, Joseph ; Albanese, Alberto Botulinum Neurotoxin Revisited – An Individualised, Patient-centric Approach for the Treatment of Dystonia and Spasticity // European neurological review, 10 (2015), 1; 28-34. doi: 10.17925/ENR.2015.10.01.28

Podaci o odgovornosti

Relja, Maja ; Jacinto, Jorge ; Jankovic, Joseph ; Albanese, Alberto

engleski

Botulinum Neurotoxin Revisited – An Individualised, Patient-centric Approach for the Treatment of Dystonia and Spasticity

Botulinum toxin (BoNT-A) has become first line of therapy in cervical dystonia, blepharospasm and spasticity. However, the current guidelines for the clinical use of BoNT-A are based on data publishem more than 20 years ago and patient satisfaction with current regiments is low. There is a need to optimise and individualise the treatment using the three available formulation of BoNT-A, as well as define parameters for switching between the formulations.

Botulinum toxin ; blepharospasm ; spasticity ; cervical dystonia ; Incobotulinumtoxin A

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

10 (1)

2015.

28-34

objavljeno

1758-3837

1758-3845

10.17925/ENR.2015.10.01.28

Povezanost rada

Kliničke medicinske znanosti

Poveznice